Kazia Therapeutics
Sydney, 26 May 2023 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, today attended and participated in the Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG) at the White House, held on Thursday, 25 May, 2023, United States' time.
In alignment with President Joe Biden and First Lady Jill Biden's commitment to end cancer, the forum brought together patients, caregivers, oncologists, researchers, and government officials to discuss and spur action against rare adult and pediatric cancers.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
